These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 23664005)

  • 1. Translating positron emission tomography studies in animals to stimulant addiction: promises and pitfalls.
    Caprioli D; Fryer TD; Sawiak SJ; Aigbirhio FI; Dalley JW
    Curr Opin Neurobiol; 2013 Aug; 23(4):597-606. PubMed ID: 23664005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positron emission tomography molecular imaging of dopaminergic system in drug addiction.
    Hou H; Tian M; Zhang H
    Anat Rec (Hoboken); 2012 May; 295(5):722-33. PubMed ID: 22467195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonhuman primate models of addiction and PET imaging: dopamine system dysregulation.
    Gould RW; Porrino LJ; Nader MA
    Curr Top Behav Neurosci; 2012; 11():25-44. PubMed ID: 22020537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modelling human drug abuse and addiction with dedicated small animal positron emission tomography.
    Dalley JW; Fryer TD; Aigbirhio FI; Brichard L; Richards HK; Hong YT; Baron JC; Everitt BJ; Robbins TW
    Neuropharmacology; 2009; 56 Suppl 1():9-17. PubMed ID: 18614184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What have positron emission tomography and 'Zippy' told us about the neuropharmacology of drug addiction?
    Cumming P; Caprioli D; Dalley JW
    Br J Pharmacol; 2011 Aug; 163(8):1586-604. PubMed ID: 20846139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain dopaminergic system changes in drug addiction: a review of positron emission tomography findings.
    Hou H; Wang C; Jia S; Hu S; Tian M
    Neurosci Bull; 2014 Oct; 30(5):765-76. PubMed ID: 25260796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonhuman primate neuroimaging and the neurobiology of psychostimulant addiction.
    Howell LL; Murnane KS
    Ann N Y Acad Sci; 2008 Oct; 1141():176-94. PubMed ID: 18991958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prefrontal cortex dopamine release measured in vivo with positron emission tomography: Implications for the stimulant paradigm.
    Hernaus D; Mehta MA
    Neuroimage; 2016 Nov; 142():663-667. PubMed ID: 26123374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PET imaging for addiction medicine: From neural mechanisms to clinical considerations.
    Wiers CE; Cabrera E; Skarda E; Volkow ND; Wang GJ
    Prog Brain Res; 2016; 224():175-201. PubMed ID: 26822359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurobiology of addiction: insight from neurochemical imaging.
    Urban NB; Martinez D
    Psychiatr Clin North Am; 2012 Jun; 35(2):521-41. PubMed ID: 22640769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What is the role of the D3 receptor in addiction? A mini review of PET studies with [(11)C]-(+)-PHNO.
    Payer D; Balasubramaniam G; Boileau I
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jul; 52():4-8. PubMed ID: 23999545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonhuman primate positron emission tomography neuroimaging in drug abuse research.
    Howell LL; Murnane KS
    J Pharmacol Exp Ther; 2011 May; 337(2):324-34. PubMed ID: 21317354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imaging neurotransmitter release by drugs of abuse.
    Martinez D; Narendran R
    Curr Top Behav Neurosci; 2010; 3():219-45. PubMed ID: 21161755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging the D3 dopamine receptor across behavioral and drug addictions: Positron emission tomography studies with [(11)C]-(+)-PHNO.
    Boileau I; Nakajima S; Payer D
    Eur Neuropsychopharmacol; 2015 Sep; 25(9):1410-20. PubMed ID: 26141509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Addiction and imaging of the living human brain.
    Gatley SJ; Volkow ND
    Drug Alcohol Depend; 1998; 51(1-2):97-108. PubMed ID: 9716933
    [No Abstract]   [Full Text] [Related]  

  • 16. From rats to humans and return: testing addiction hypotheses by combined PET imaging and self-reported measures of psychostimulant effects. Commentary on Volkow et al. 'Role of dopamine in drug reinforcement and addiction in humans: results from imaging studies'.
    Di Chiara G
    Behav Pharmacol; 2002 Sep; 13(5-6):371-7. PubMed ID: 12394413
    [No Abstract]   [Full Text] [Related]  

  • 17. Role of dopamine in drug reinforcement and addiction in humans: results from imaging studies.
    Volkow ND; Fowler JS; Wang GJ
    Behav Pharmacol; 2002 Sep; 13(5-6):355-66. PubMed ID: 12394411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Food addiction: A common neurobiological mechanism with drug abuse.
    Lindgren E; Gray K; Miller G; Tyler R; Wiers CE; Volkow ND; Wang GJ
    Front Biosci (Landmark Ed); 2018 Jan; 23(5):811-836. PubMed ID: 28930574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of Nonhuman Primates in Substance Use Disorders Research.
    Banks ML; Czoty PW; Negus SS
    ILAR J; 2017 Dec; 58(2):202-215. PubMed ID: 28531265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain imaging in nonhuman primates: insights into drug addiction.
    Nader MA; Czoty PW
    ILAR J; 2008; 49(1):89-102. PubMed ID: 18172336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.